RxDoctor Payments Data

Molly Warnock

Medical · Annapolis, MDNPI 1821628751

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,246, 2.3 times the $971 reported in 2021. Among medical clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,842in general payments, 2019–2025

Across 392 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$917
  • Regeneron Healthcare Solutions, Inc.$791
  • Incyte Corporation$635
  • Pfizer$626
  • Johnson & Johnson$575
  • E.r. Squibb & Sons, L.L.C.$549
  • plus $4K from 24 others

What the payments were for

  • Food & beverage$7,61797%
  • Education$2253%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,842 in reported general payments places this provider in the 90th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland

Medicare billing

Part B allowed, 2024
$134,956
Medicare patients
428
Services billed
2,561

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready PenSecukinumab11$100,843
Tretinoin36$2,564
Metronidazole34$1,653
Clobetasol Propionate31$1,410
Ketoconazole85$1,347
Triamcinolone Acetonide82$774
Fluocinolone AcetonideFluocinolone/Shower Cap17$726
Clindamycin Phosphate22$674
Levocetirizine Dihydrochloride18$568
Mometasone Furoate29$567
Betamethasone Valerate19$549
Ammonium Lactate17$333
Nystatin20$329
Hydrocortisone32$178
Mupirocin18$152

Paid to pharmacies, not to this prescriber.

Other medical in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →